Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Uma Mahadevan, MD
Conference Coverage
Considerations in Managing Pregnancy Among Patients with IMIDs
06/21/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Uma Mahadevan, MD, and Christopher Robinson, MD, discuss the importance of preconception counseling for a patient with immune-mediated inflammatory disease to boost their chances of achieving and maintaining a healthy pregnancy.
Uma Mahadevan, MD, and Christopher Robinson, MD, discuss the importance of preconception counseling for a patient with immune-mediated inflammatory disease to boost their chances of achieving and maintaining a healthy pregnancy.
Uma Mahadevan, MD, and...
06/21/2023
Autoimmune
Jeff Sparks
Conference Coverage
Therapeutic Drug Monitoring in IMIDs
04/30/2023
Drs Adam Cheifetz, Jeffrey Sparks and Martina Porter discussed the applications of proactive and reactive therapeutic monitoring among patients on various immunosuppressive therapies in inflammatory bowel disease, rheumatology, and...
Drs Adam Cheifetz, Jeffrey Sparks and Martina Porter discussed the applications of proactive and reactive therapeutic monitoring among patients on various immunosuppressive therapies in inflammatory bowel disease, rheumatology, and...
Drs Adam Cheifetz, Jeffrey...
04/30/2023
Autoimmune
doctor with patient
Conference Coverage
Key Insights: Vaccines and Infectious Diseases
04/28/2023
Jessica Garlewicz, Digital Managing Editor
During their session, “Ask the Expert: Infectious Diseases,” presented at the Interdisciplinary Autoimmune Summit, Alexis Ogdie, MD, MSCE, and Kevin Winthrop, MD, MPH, held a discussion on vaccinations in relation to infectious diseases.
During their session, “Ask the Expert: Infectious Diseases,” presented at the Interdisciplinary Autoimmune Summit, Alexis Ogdie, MD, MSCE, and Kevin Winthrop, MD, MPH, held a discussion on vaccinations in relation to infectious diseases.
During their session, “Ask the...
04/28/2023
The Dermatologist
Stephen Hanauer
Conference Coverage
Breaking Through the Therapeutic Ceiling: the Future of Inflammatory Bowel Disease
04/28/2023
A panel led by inflammatory bowel disease specialists Stephen B. Hanauer and Adam Cheifetz reviewed the importance of working to break through a therapeutic ceiling and developing precision medicine in propelling the practice of...
A panel led by inflammatory bowel disease specialists Stephen B. Hanauer and Adam Cheifetz reviewed the importance of working to break through a therapeutic ceiling and developing precision medicine in propelling the practice of...
A panel led by inflammatory...
04/28/2023
Autoimmune
Kaplan G
Conference Coverage
Environmental Effects on IMIDs
04/28/2023
Riya Gandhi, MA, Associate Editor
On the third day of the 2023 Interdisciplinary Autoimmune Summit, Gilaad Kaplan, MD, MPH, FCAHS, presented his session, “The Effects of the Environment on Immune-mediated Diseases (IMIDs): Inflammatory Bowel Disease (IBD) as a Case Study.”
On the third day of the 2023 Interdisciplinary Autoimmune Summit, Gilaad Kaplan, MD, MPH, FCAHS, presented his session, “The Effects of the Environment on Immune-mediated Diseases (IMIDs): Inflammatory Bowel Disease (IBD) as a Case Study.”
On the third day of the 2023...
04/28/2023
The Dermatologist
Leonard Calabrese, DO
Conference Coverage
A Forward Look at IMIDs
04/27/2023
Coleen Stern, MA, Senior Managing Editor
Joel M. Gelfand, MD, MSCE; Leonard Calabrese, DO; Adam S. Cheifetz, MD; and Stephen B. Hanauer, MD, joined together in a roundtable discussion to look at the future of immune-mediated inflammatory diseases.
Joel M. Gelfand, MD, MSCE; Leonard Calabrese, DO; Adam S. Cheifetz, MD; and Stephen B. Hanauer, MD, joined together in a roundtable discussion to look at the future of immune-mediated inflammatory diseases.
Joel M. Gelfand, MD, MSCE;...
04/27/2023
The Dermatologist
drugs
Conference Coverage
Steroids and the Treatment of Autoimmune Conditions
04/27/2023
Riya Gandhi, MA, Associate Editor
On the second day of the 2023 Interdisciplinary Autoimmune Summit, Stephen B. Hanauer, MD, and Soumya Reddy, MD, reviewed indications for steroids in immune-mediated inflammatory diseases and the efficacy of steroid-sparing therapies.
On the second day of the 2023 Interdisciplinary Autoimmune Summit, Stephen B. Hanauer, MD, and Soumya Reddy, MD, reviewed indications for steroids in immune-mediated inflammatory diseases and the efficacy of steroid-sparing therapies.
On the second day of the 2023...
04/27/2023
The Dermatologist
multidisciplinary healthcare
Conference Coverage
Combined Clinics – Combined Management Strategies
04/27/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Comanagement strategies are often beneficial to patients with immune-mediated inflammatory disease since they are at a higher risk of developing other autoimmune conditions.
Comanagement strategies are often beneficial to patients with immune-mediated inflammatory disease since they are at a higher risk of developing other autoimmune conditions.
Comanagement strategies are...
04/27/2023
Autoimmune
Alexis Ogdie
Conference Coverage
The Future of Rheumatology: Targeting Treatments, Promoting Multidisciplinary Care
04/27/2023
An all-star panel of specialists in immunology, rheumatology, IBD gastroenterology, and dermatology held a wide-ranging discussion about the history, the present, and the future of treatment for immune-mediated inflammatory diseases (IMIDs)...
An all-star panel of specialists in immunology, rheumatology, IBD gastroenterology, and dermatology held a wide-ranging discussion about the history, the present, and the future of treatment for immune-mediated inflammatory diseases (IMIDs)...
An all-star panel of specialists...
04/27/2023
Autoimmune
psoriasis
Conference Coverage
Immune-mediated Inflammatory Diseases: Past and Current Treatments
04/26/2023
Jessica Garlewicz, Digital Managing Editor
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
Christopher T. Ritchlin, MD,...
04/26/2023
The Dermatologist
Joel Gelfand
Conference Coverage
Inflammatory Skin Conditions: Prevention of Cardiovascular Disease
04/26/2023
Being more aggressive in managing traditional cardiovascular risk factors among patients with more severe psoriasis requires a team-based approach involving the dermatologist, cardiologist, and primary care providers.
Being more aggressive in managing traditional cardiovascular risk factors among patients with more severe psoriasis requires a team-based approach involving the dermatologist, cardiologist, and primary care providers.
Being more aggressive in...
04/26/2023
Autoimmune
Peter Lio
Conference Coverage
JAK Inhibitor Safety for Atopic Dermatitis
04/26/2023
Riya Gandhi, MA, Associate Editor
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
On the first day of the 2023...
04/26/2023
The Dermatologist
Joel Gelfand, MD
Conference Coverage
Predictions on the Future of Dermatology
04/26/2023
Coleen Stern, MA, Senior Managing Editor
Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
Joel M. Gelfand, MD, MSCE, and...
04/26/2023
The Dermatologist
Leonard Calabrese, DO
Conference Coverage
Leonard Calabrese, DO, on COVID-19 and the Immunocompromised Patient
04/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Leonard Calabrese, DO, discussed the risks and complications of SARS-CoV-2 among immunocompromised patients at the Interdisciplinary Autoimmune Summit virtual session.
Leonard Calabrese, DO, discussed the risks and complications of SARS-CoV-2 among immunocompromised patients at the Interdisciplinary Autoimmune Summit virtual session.
Leonard Calabrese, DO, discussed...
04/26/2023
Autoimmune
skin of color prurigo nodularis
Conference Coverage
Prurigo Nodularis: Features and Burden of Disease
04/26/2023
Jessica Garlewicz, Digital Managing Editor
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the...
04/26/2023
The Dermatologist
Stephen Hanauer
Conference Coverage
Stephen B. Hanauer, MD, on Human Models of Inflammatory Bowel Disease
04/26/2023
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a...
04/26/2023
Autoimmune
Leonard Calabrese, DO
Conference Coverage
Leonard Calabrese, DO, on Managing the High-Risk Outpatient
05/27/2022
In his presentation to the Interdisciplinary Autoimmune Summit, Dr Leonard Calabrese proposed strategies for implementing pre-exposure prophylaxis, post-exposure therapy, and careful choice of medical therapy for autoimmune diseases among...
In his presentation to the Interdisciplinary Autoimmune Summit, Dr Leonard Calabrese proposed strategies for implementing pre-exposure prophylaxis, post-exposure therapy, and careful choice of medical therapy for autoimmune diseases among...
In his presentation to the...
05/27/2022
Autoimmune
Alexis Ogdie, MD
Alexis Ogdie, MD, on Combined Clinics — Combined Goals
05/09/2022
Dr Ogdie gives a review of her presentation at the 2022 Interdisciplinary Autoimmune Summit, with Dr Joseph Merola, on the benefits of combined clinics for treating patients with autoimmune disorders.
Dr Ogdie gives a review of her presentation at the 2022 Interdisciplinary Autoimmune Summit, with Dr Joseph Merola, on the benefits of combined clinics for treating patients with autoimmune disorders.
Dr Ogdie gives a review of her...
05/09/2022
Autoimmune
Cassandra Calabrese, DO
Conference Coverage
Vaccine Recommendations for Patients With IMIDs
04/24/2022
At the 2022 Interdisciplinary Autoimmune Summit, Dr Cassandra Calabrese discussed recommendations and best practices that exist for different vaccines within the population of patients with immune-mediated inflammatory diseases.
At the 2022 Interdisciplinary Autoimmune Summit, Dr Cassandra Calabrese discussed recommendations and best practices that exist for different vaccines within the population of patients with immune-mediated inflammatory diseases.
At the 2022 Interdisciplinary...
04/24/2022
Autoimmune
prescription
Conference Coverage
Improving Treatment Outcomes: Biosimilars
04/24/2022
Jessica Garlewicz, Associate Digital Editor
Jonathan Kay, MD, presented his session, “Biosimilars in the Treatment of IMIDs: A Potential Path to Improved Outcomes”, at IAS 2022.
Jonathan Kay, MD, presented his session, “Biosimilars in the Treatment of IMIDs: A Potential Path to Improved Outcomes”, at IAS 2022.
Jonathan Kay, MD, presented his...
04/24/2022
The Dermatologist
blood clot
Conference Coverage
Cardiovascular Risks Associated With IMIDs
04/23/2022
Coleen Stern, Senior Managing Editor
Joel Gelfand, MD, MSCE, presented the session “Cardiovascular Risk and Immune-Mediated Inflammatory Disorders.”
Joel Gelfand, MD, MSCE, presented the session “Cardiovascular Risk and Immune-Mediated Inflammatory Disorders.”
Joel Gelfand, MD, MSCE,...
04/23/2022
The Dermatologist
Michelle Petri
Video
Michelle Petri, MD, on Improving Outcomes in SLE by Individualizing Care
04/23/2022
Dr Petri, from Johns Hopkins University, reviews her presentation at the Interdisciplinary Autoimmune Summit on the importance of providing individualized care for patients with systemic lupus erythematosus.
Dr Petri, from Johns Hopkins University, reviews her presentation at the Interdisciplinary Autoimmune Summit on the importance of providing individualized care for patients with systemic lupus erythematosus.
Dr Petri, from Johns Hopkins...
04/23/2022
Rheumatology & Arthritis
combined clinics - handshake
Conference Coverage
Combined Clinics – Treating Patients as a Whole
04/22/2022
Riya Gandhi, MA, Associate Editor
Dr Joseph F Merola, MD, MMSc and Dr Alexis Ogdie, MD, MSCE got together to discuss combined clinics touched base on “accessing the role of interdisciplinary care in optimizing disease outcomes and then understanding how combined approaches to...
Dr Joseph F Merola, MD, MMSc and Dr Alexis Ogdie, MD, MSCE got together to discuss combined clinics touched base on “accessing the role of interdisciplinary care in optimizing disease outcomes and then understanding how combined approaches to...
Dr Joseph F Merola, MD, MMSc and...
04/22/2022
The Dermatologist
Lisa Malter, MD
Conference Coverage
Care Disparities in Immune-Mediated Diseases
04/22/2022
At the 2022 Interdisciplinary Autoimmune Summit, Dr Lisa Malter presented on disparities that exist in care for immune-mediated diseases and how practitioners can work to reduce these inequities.
At the 2022 Interdisciplinary Autoimmune Summit, Dr Lisa Malter presented on disparities that exist in care for immune-mediated diseases and how practitioners can work to reduce these inequities.
At the 2022 Interdisciplinary...
04/22/2022
Autoimmune
Psoriasis
Conference Coverage
Interleukin Inhibitors for Moderate to Severe Psoriasis
04/22/2022
Coleen Stern, Senior Managing Editor
April Armstrong, MD, MPH, presented the session “The Role of Interleukin Inhibitors in the Treatment of Moderate to Severe Psoriasis.”
April Armstrong, MD, MPH, presented the session “The Role of Interleukin Inhibitors in the Treatment of Moderate to Severe Psoriasis.”
April Armstrong, MD, MPH,...
04/22/2022
The Dermatologist
Psoriasis
Conference Coverage
A Deep Dive Into Combination Therapy
04/22/2022
Coleen Stern, Senior Managing Editor
Joseph Merola, MD, MMSc, and Adam Cheifetz, MD, presented their discussion-based session, “Deep Dive: Combination Therapy Approaches.”
Joseph Merola, MD, MMSc, and Adam Cheifetz, MD, presented their discussion-based session, “Deep Dive: Combination Therapy Approaches.”
Joseph Merola, MD, MMSc, and...
04/22/2022
The Dermatologist
skin cancer examination
Conference Coverage
Collaborative Cases: Inflammation and Malignancies
04/22/2022
Jessica Garlewicz, Associate Digital Editor
On the 2nd day of the 9th Annual Interdisciplinary Autoimmune Summit, Joseph Merola, MD, MMSc, and Adam Cheifetz, MD, opened with their session, “Collaborative Cases in IMIDs".
On the 2nd day of the 9th Annual Interdisciplinary Autoimmune Summit, Joseph Merola, MD, MMSc, and Adam Cheifetz, MD, opened with their session, “Collaborative Cases in IMIDs".
On the 2nd day of the 9th Annual...
04/22/2022
The Dermatologist
JAK-Treatment
Conference Coverage
Best of Dermatology 2021: JAK Inhibitors
04/22/2022
Jessica Garlewicz, Associate Digital Editor
In the session, “Editors Focus - Best of 2021 Dermatology, Gastroenterology & Rheumatology” presented at IAS 2022, Joel Gelfand, MD MSCE, shared some exciting news on the use of JAKs in dermatology.
In the session, “Editors Focus - Best of 2021 Dermatology, Gastroenterology & Rheumatology” presented at IAS 2022, Joel Gelfand, MD MSCE, shared some exciting news on the use of JAKs in dermatology.
In the session, “Editors Focus -...
04/22/2022
The Dermatologist
pustular psoriasis
Conference Coverage
A Deep Dive Into Dual Targeting
04/21/2022
Coleen Stern, Senior Managing Editor
Stephen Hanauer, MD, FACG; Joel Gelfand, MD, MSCE; and Leonard Calabrese, DO, got together to discuss dual targeted therapy.
Stephen Hanauer, MD, FACG; Joel Gelfand, MD, MSCE; and Leonard Calabrese, DO, got together to discuss dual targeted therapy.
Stephen Hanauer, MD, FACG; Joel...
04/21/2022
The Dermatologist
Psoriasis_COVID-19_COVID
Conference Coverage
The Impact of IMID Treatment on COVID-19 Risk
04/21/2022
Riya Gandhi, MA, Associate Editor
Joel M. Gelfand, MD, MSCE, kicked off the session by saying, “In spring 2020, COVID toes were reported to occur 1 to 4 weeks post onset of COVID-19 symptoms.”
Joel M. Gelfand, MD, MSCE, kicked off the session by saying, “In spring 2020, COVID toes were reported to occur 1 to 4 weeks post onset of COVID-19 symptoms.”
Joel M. Gelfand, MD, MSCE,...
04/21/2022
The Dermatologist
severe psoriasis
Conference Coverage
Skin Disease States and Remissions
04/21/2022
Jessica Garlewicz, Associate Digital Editor
At IAS, Joseph Merola, MD, MMSc, and Adam Cheifetz, MD, presented their discussion-based session, “Deep Dive: Can We Achieve Remission?"
At IAS, Joseph Merola, MD, MMSc, and Adam Cheifetz, MD, presented their discussion-based session, “Deep Dive: Can We Achieve Remission?"
At IAS, Joseph Merola, MD, MMSc,...
04/21/2022
The Dermatologist
psoriasis on arm
Conference Coverage
Collaborating in IMIDs: Anti-TNFs
04/21/2022
Jessica Garlewicz, Associate Digital Editor
During the Interdisciplinary Autoimmune Summit , Joseph Merola, MD, MMSc, joined his colleague Adam Cheifetz, MD, for their session, “Collaborative Cases in IMIDs.”
During the Interdisciplinary Autoimmune Summit , Joseph Merola, MD, MMSc, joined his colleague Adam Cheifetz, MD, for their session, “Collaborative Cases in IMIDs.”
During the Interdisciplinary...
04/21/2022
The Dermatologist
Wan-Fai Ng, PhD
Conference Coverage
The Complex Network of Potential Fatigue Causes in IMIDs
04/21/2022
At the 2022 Interdisciplinary Autoimmune Summit, Dr Wan-Fai Ng presented on the issue of fatigue in immune-mediated inflammatory diseases, including the impact it has on patients, potential contributing mechanisms, and approaches for managing...
At the 2022 Interdisciplinary Autoimmune Summit, Dr Wan-Fai Ng presented on the issue of fatigue in immune-mediated inflammatory diseases, including the impact it has on patients, potential contributing mechanisms, and approaches for managing...
At the 2022 Interdisciplinary...
04/21/2022
Autoimmune
Hanauer
Videos
Stephen Hanauer, MD, on Beyond TNFis: Optimizing IL-12/23 and IL-23 Inhibitors in IBD
04/21/2022
Dr Hanauer, from Northwestern Feinberg School of Medicine, reviews his presentation at the Interdisciplinary Autoimmune Summit on the use of interleukin 12/23 and interleukin 12 inhibitors in the treatment of inflammatory bowel disease.
Dr Hanauer, from Northwestern Feinberg School of Medicine, reviews his presentation at the Interdisciplinary Autoimmune Summit on the use of interleukin 12/23 and interleukin 12 inhibitors in the treatment of inflammatory bowel disease.
Dr Hanauer, from Northwestern...
04/21/2022
Advances in Inflammatory Bowel Disease Network
Osterholm
Conference Coverage
How COVID-19 Will Change the World
04/21/2022
Infectious disease expert Michael Osterholm, PhD, MPH, calls for rebuilding public health, fixing a broken health information system, and planning for the exception instead of the average, to better respond to pandemics.
Infectious disease expert Michael Osterholm, PhD, MPH, calls for rebuilding public health, fixing a broken health information system, and planning for the exception instead of the average, to better respond to pandemics.
Infectious disease expert...
04/21/2022
Autoimmune
Hanauer
Video
Stephen Hanauer, MD, on Immunologic Lessons From COVID 19
04/21/2022
Dr Hanauer, professor of medicine at Northwestern Medicine in Chicago, discusses his presentation at the Interdisciplinary Autoimmune Summit 2022 on lessons learned during the pandemic about risks to and care of patients with inflammatory...
Dr Hanauer, professor of medicine at Northwestern Medicine in Chicago, discusses his presentation at the Interdisciplinary Autoimmune Summit 2022 on lessons learned during the pandemic about risks to and care of patients with inflammatory...
Dr Hanauer, professor of...
04/21/2022
Advances in Inflammatory Bowel Disease Network
Jonathan Ky
Conference Coverage
Biosimilars Offer Opportunities to Improve Access and Outcomes for Patients With IMIDs
04/27/2012
Dr Jonathan Kay of the UMass Chan Medical School explained how the advent of biosimilars in the field of immune-mediated inflammatory diseases can potentially expand access to and drive down costs of treatment without loss of safety or...
Dr Jonathan Kay of the UMass Chan Medical School explained how the advent of biosimilars in the field of immune-mediated inflammatory diseases can potentially expand access to and drive down costs of treatment without loss of safety or...
Dr Jonathan Kay of the UMass...
04/27/2012
Autoimmune
Alexis Ogdie, MD
Videos
Alexis Ogdie, MD, on The Burden of Comorbidities in Inflammatory Disorders
04/26/2011
Dr Ogdie gives a recap of her presentation at the 2022 Interdisciplinary Autoimmune Summit on common comorbidities to be aware of in patients with inflammatory disorders.
Dr Ogdie gives a recap of her presentation at the 2022 Interdisciplinary Autoimmune Summit on common comorbidities to be aware of in patients with inflammatory disorders.
Dr Ogdie gives a recap of her...
04/26/2011
Autoimmune
Calabrese
Conference Coverage
Leonard Calabrese, DO, on Interdisciplinary Management of Immune-Related Adverse Events
04/23/2011
Leonard Calabrese, DO, from Cleveland Clinic, reviewed adverse events that can be caused by immunotherapy for cancer care, therapies for these immune-related effects, and the importance of consultation among oncologists, rheumatologists,...
Leonard Calabrese, DO, from Cleveland Clinic, reviewed adverse events that can be caused by immunotherapy for cancer care, therapies for these immune-related effects, and the importance of consultation among oncologists, rheumatologists,...
Leonard Calabrese, DO, from...
04/23/2011
Autoimmune
David Hudesman, MD
Videos
David Hudesman, MD, on The Promise of Sphingosine-1-Phosphate Receptor Modulators in IBD
04/22/2011
Dr Hudesman reviews his talk from the 2022 Interdisciplinary Autoimmune Summit on emerging challenges for the management of patients with IBD and the promise of sphingosine-1-phosphate receptor modulators.
Dr Hudesman reviews his talk from the 2022 Interdisciplinary Autoimmune Summit on emerging challenges for the management of patients with IBD and the promise of sphingosine-1-phosphate receptor modulators.
Dr Hudesman reviews his talk...
04/22/2011
Advances in Inflammatory Bowel Disease Network

About IAS

The 9th Annual Interdisciplinary Autoimmune Summit, IAS, is a 4-day virtual event, dedicated to connecting experts in the fields of rheumatology, dermatology, and gastroenterology to collaborate on innovative treatment strategies for patients with immune-mediated inflammatory diseases (IMIDs).

This one-of-a-kind meeting forces out-of-the-box thinking, powerful collaborations, and groundbreaking treatment methods that are necessary for life-changing care options.

This conference is sure to be an engaging, interactive, educational experience for attendees, with several opportunities to network with both faculty and attendees.

THINK DIFFERENTLY.

Advertisement

Autoimmune Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement